TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with Jer Thorp. The former Data Artist in Residence at the New York Times, he talks about his book: “Living in Data – A Citizen’s Guide to a Better Information Future”. Then Joe Hernandez, the Founder and CEO of Blue Water Vaccines tells us about their quest for a universal flu vaccine. Even more unusual? Along the way, they also found a Dodo bird.

On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers. And Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers. And Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

On this week’s Tech Nation, Moira speaks with Dr. George Yancopoulos, the President and Chief Scientific Officer of Regeneron. Its innovative COVID treatment directly infuses antibodies. But how do get students to become innovative scientists? The Regeneron Science Talent Search. Then the challenge of diagnosing liver disease. Dr. Caroline Loew, the President and CEO of Glympse Bio, talks about their approach to diagnosing and tracking the progression of the liver condition, NASH, and its potential in other diseases, as well.

On this week’s Tech Nation, Moira speaks with Dr. George Yancopoulos, the President and Chief Scientific Officer of Regeneron. Its innovative COVID treatment directly infuses antibodies. But how do get students to become innovative scientists? The Regeneron Science Talent Search. Then the challenge of diagnosing liver disease. Dr. Caroline Loew, the President and CEO of Glympse Bio, talks about their approach to diagnosing and tracking the progression of the liver condition, NASH, and its potential in other diseases, as well.

In this week’s Tech Nation, Moira speaks with Dr. Andrew Steele in a FOLLOW-ON science-focused interview on the latest science behind aging. His book is “Ageless … The New Science of Getting Older without Getting Old.” And then, an excerpt from Dr. Thomas Rando’s 2020 interview. A co-founder of Fountain Therapeutics, he tells us about their science and their efforts to potentially reverse the aging process.

In this week’s Tech Nation, Moira speaks with Dr. Andrew Steele in a FOLLOW-ON science-focused interview on the latest science behind aging. His book is “Ageless … The New Science of Getting Older without Getting Old.” And then, an excerpt from Dr. Thomas Rando’s 2020 interview. A co-founder of Fountain Therapeutics, he tells us about their science and their efforts to potentially reverse the aging process.

On this week’s Tech Nation, Moira speaks with Journalists Dade Hayes & Dawn Chmielewski about “Binge Times: Inside Hollywood’s Furious Billion-Dollar Battle to Take Down Netflix”. From the stock plunge of Netflix to the rise of Bridgerton, it’s a streaming war for our attention. Then in Biotech, could “sticky proteins” lead to Alzheimer’s, Parkinson’s, ALS and more? Dr. Maria Maccecchini, Founder, President and CEO of Annovis Bio, tells us about their approach.

On this week’s Tech Nation, Moira speaks with Journalists Dade Hayes & Dawn Chmielewski about “Binge Times: Inside Hollywood’s Furious Billion-Dollar Battle to Take Down Netflix”. From the stock plunge of Netflix to the rise of Bridgerton, it’s a streaming war for our attention. Then in Biotech, could “sticky proteins” lead to Alzheimer’s, Parkinson’s, ALS and more? Dr. Maria Maccecchini, Founder, President and CEO of Annovis Bio, tells us about their approach.

On this week’s Tech Nation, Moira speaks with Neuroscientist Daniel Levitin about his book “Successful Aging … A Neuroscientist Explores the Power and Potential of Our Lives”. And Dr. Cameron Turtle from Eidos Therapeutics tells us that of the 6 Million Americans living with the medical condition known as Heart Failure, several hundred thousand have a special type, which was thought to be rare, but is being underdiagnosed. It’s known by its initials: ATTR. Eidos is working on a treatment.